{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:41:36Z","timestamp":1786718496961,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Trichol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijt.ijt_47_17","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T07:24:07Z","timestamp":1516778647000},"page":"154","source":"Crossref","is-referenced-by-count":16,"title":["Detection of tumor necrosis factor-alpha in nonlesional tissues of alopecia areata patients: A prove for a systemic disease"],"prefix":"10.4103","volume":"9","author":[{"given":"YasserMostsfa","family":"Gohary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DinaSabry","family":"Abdel Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-7753.216027-1","first-page":"628","volume-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"key-10.4103\/0974-7753.216027-2","first-page":"364","volume-title":"Alopecia areata: Autoimmune basis of hair loss","author":"Alexis","year":"2004","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/0974-7753.216027-3","first-page":"112","volume-title":"Role of cytotoxic T cells in chronic alopecia areata","author":"Bodemer","year":"2000","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0974-7753.216027-4","first-page":"942","volume-title":"Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: A possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata","author":"Philpott","year":"1996","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0974-7753.216027-5","first-page":"421","volume-title":"Cytokines in alopecia areata: Contrasting cytokine profiles in localized form and extensive form (alopecia universalis)","author":"Teraki","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0974-7753.216027-6","unstructured":"Koubanova A, Gadjlgoroeva A. On the Problem of Pathogenetic Heterogeneity of Alopecia Areata. EHRS Brussels: Conference Abstracts; 27-29 June, 2002. p. 13."},{"key":"key-10.4103\/0974-7753.216027-7","first-page":"159","volume-title":"The role of cell-mediated immune response in pathogenesis of alopecia areata","author":"Lis","year":"2001","journal-title":"Wiad Lek"},{"key":"key-10.4103\/0974-7753.216027-8","first-page":"367","volume-title":"Alopecia areata: Genetic complexity underlies clinical heterogeneity","author":"Dudda-Subramanya","year":"2007","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/0974-7753.216027-9","first-page":"2019","volume-title":"Lymphocytes, neuropeptides, and genes involved in alopecia areata","author":"Gilhar","year":"2007","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0974-7753.216027-10","first-page":"392","volume-title":"Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans","author":"Carroll","year":"2002","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0974-7753.216027-11","first-page":"1082","volume-title":"Etanercept does not effectively treat moderate to severe alopecia areata: An open-label study","author":"Strober","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.216027-12","first-page":"409","volume-title":"Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy","author":"Barahmani","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0974-7753.216027-13","first-page":"176","volume-title":"Characterization of hair follicle antigens targeted by the anti-hair follicle immune response","author":"Tobin","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"key":"key-10.4103\/0974-7753.216027-14","first-page":"479","volume-title":"Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-a blocker agents: Report of five cases and review of the literature","author":"Ferran","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0974-7753.216027-15","first-page":"185","volume-title":"Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab","author":"Fabre","year":"2008","journal-title":"Dermatology"},{"key":"key-10.4103\/0974-7753.216027-16","first-page":"380","volume-title":"Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab)","author":"Chaves","year":"2008","journal-title":"Dermatology"},{"key":"key-10.4103\/0974-7753.216027-17","first-page":"923","volume-title":"Psoriasiform eruption associated with alopecia areata during infliximab therapy","author":"Nakagomi","year":"2009","journal-title":"Clin Exp Dermatol"}],"container-title":["International Journal of Trichology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:35:43Z","timestamp":1786714543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_47_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["216027"],"URL":"https:\/\/doi.org\/10.4103\/ijt.ijt_47_17","relation":{},"ISSN":["0974-7753"],"issn-type":[{"value":"0974-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}